Strategic Partnerships ARENSIA has already established regional academic collaborations in Romania with UMF Cluj, suggesting a proven path for expanding Phase I sites through university partnerships and clinical pharmacology education programs to access larger patient pools.

Eastern Europe Focus Active engagement in Eastern Europe with clinics in Bucharest and Cluj-Napoca, plus Pasithea Therapeutics collaborations, indicates a ripe market for expanding speed-to-data capabilities and cost advantages in this region through co-sponsored trials and local CRO relationships.

Proof-of-Concept Demand ARENSIA’s value proposition centers on faster and cheaper early-phase proof-of-concept trials with diverse patient populations, presenting an opportunity to target sponsors seeking accelerated go/no-go decisions and reduced development risk.

Award and Purpose Recognition for safe handling of cancer medicines and involvement in patient safety initiatives (Yellow Hand) highlights a reputational asset that can be leveraged to attract sponsors prioritizing risk management, compliance, and patient-centered trial conduct.

Integrated Clinic Network Owned clinics integrated with dedicated research physicians and large patient access provide a scalable platform for sponsors; sales outreach can emphasize end-to-end trial execution speed, recruitment efficiency, and streamlined decision-making as a differentiator from traditional models.